[go: up one dir, main page]

CU20110168A7 - Derivados de benzofuranilo - Google Patents

Derivados de benzofuranilo

Info

Publication number
CU20110168A7
CU20110168A7 CU20110168A CU20110168A CU20110168A7 CU 20110168 A7 CU20110168 A7 CU 20110168A7 CU 20110168 A CU20110168 A CU 20110168A CU 20110168 A CU20110168 A CU 20110168A CU 20110168 A7 CU20110168 A7 CU 20110168A7
Authority
CU
Cuba
Prior art keywords
benzofuranilo
derivatives
formula
glucokinase
disorders
Prior art date
Application number
CU20110168A
Other languages
English (en)
Other versions
CU24036B1 (es
Inventor
Anthony Lai Ling
Jeffrey Allen Pfefferkorn
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42124287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU20110168(A7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer filed Critical Pfizer
Publication of CU20110168A7 publication Critical patent/CU20110168A7/es
Publication of CU24036B1 publication Critical patent/CU24036B1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona compuestos de fórmula (I) ESPACIO PARA LA FÓRMULA que actúan como activadores de glucocinasa; composiciones farmacéuticas de los mismos; y procedimientos para tratar enfermedades, trastornos o afecciones mediadas por glucocinasa.
CU2011000168A 2009-03-11 2011-09-02 Derivados de benzofuranilo CU24036B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15909909P 2009-03-11 2009-03-11
PCT/IB2010/050943 WO2010103437A1 (en) 2009-03-11 2010-03-04 Benzofuranyl derivatives used as glucokinase inhibitors

Publications (2)

Publication Number Publication Date
CU20110168A7 true CU20110168A7 (es) 2012-02-15
CU24036B1 CU24036B1 (es) 2014-10-30

Family

ID=42124287

Family Applications (1)

Application Number Title Priority Date Filing Date
CU2011000168A CU24036B1 (es) 2009-03-11 2011-09-02 Derivados de benzofuranilo

Country Status (38)

Country Link
US (2) US8455496B2 (es)
EP (2) EP2604604A1 (es)
JP (1) JP5086480B2 (es)
KR (1) KR101295937B1 (es)
CN (1) CN102388038B (es)
AP (1) AP3179A (es)
AR (1) AR075729A1 (es)
AU (1) AU2010222589B2 (es)
BR (1) BRPI1013246B1 (es)
CA (1) CA2754681C (es)
CL (1) CL2011002185A1 (es)
CO (1) CO6430427A2 (es)
CR (1) CR20110467A (es)
CU (1) CU24036B1 (es)
DK (1) DK2406253T3 (es)
DO (1) DOP2011000279A (es)
EA (1) EA018894B1 (es)
EC (1) ECSP11011306A (es)
ES (1) ES2427279T3 (es)
GE (1) GEP20156239B (es)
HK (1) HK1164281A1 (es)
HR (1) HRP20130661T1 (es)
IL (1) IL214942A (es)
MA (1) MA33119B1 (es)
MY (1) MY151246A (es)
NI (1) NI201100166A (es)
NZ (1) NZ595024A (es)
PE (1) PE20120668A1 (es)
PL (1) PL2406253T3 (es)
PT (1) PT2406253E (es)
RS (1) RS52903B (es)
SI (1) SI2406253T1 (es)
TN (1) TN2011000454A1 (es)
TW (1) TWI383981B (es)
UA (1) UA99882C2 (es)
UY (1) UY32480A (es)
WO (1) WO2010103437A1 (es)
ZA (1) ZA201106632B (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012501800A1 (en) 2010-03-19 2012-12-10 Pfizer 2,3 dihydro- 1h - inden- 1 - yl -2,7 -diazaspirol [ 3.5 ] nonane derivatives and their use as antagonists or inverse agonists of the ghrelin receptor
JP5647356B2 (ja) 2010-10-29 2014-12-24 ファイザー・インク Ｎ１／Ｎ２−ラクタムアセチル−ＣｏＡカルボキシラーゼ阻害剤
DK2699576T3 (en) 2011-04-22 2016-02-15 Pfizer Pyrazolospiroketon derivatives for use as acetyl-CoA carboxylase inhibitors
JP2014520879A (ja) 2011-07-15 2014-08-25 ファイザー・インク Ｇｐｒ１１９調節因子
MX2014000855A (es) 2011-07-22 2014-04-30 Pfizer Moduladores receptores de glucagon de quinolinilo.
WO2013030713A1 (en) 2011-08-31 2013-03-07 Pfizer Inc. Hexahydropyrano [3,4-d][1,3] thiazin-2-amine compounds
MX351299B (es) 2011-11-11 2017-10-10 Pfizer 2-tiopirimidinonas.
CN104334557A (zh) 2012-04-06 2015-02-04 辉瑞公司 二酰基甘油酰基转移酶2抑制剂
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
CA2872154C (en) 2012-05-04 2016-08-23 Pfizer Inc. Heterocyclic substituted hexahydropyrano [3,4-d] [1,3] thiazin-2-amine compounds as inhibitors of app, bace1 and bace2
EP2897964A1 (en) 2012-09-20 2015-07-29 Pfizer Inc. Alkyl-substituted hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds
EP2931731A1 (en) 2012-12-11 2015-10-21 Pfizer Inc. Hexahydropyrano [3,4-d][1,3]thiazin-2-amine compounds as inhibitors of bace1
CA2893333C (en) 2012-12-19 2017-10-24 Pfizer Inc. Carbocyclic-and heterocyclic-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
EP2956458B1 (en) 2013-02-13 2017-08-09 Pfizer Inc Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
US9233981B1 (en) 2013-02-15 2016-01-12 Pfizer Inc. Substituted phenyl hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
EP3055300B1 (en) 2013-10-09 2018-03-07 Pfizer Inc Antagonists of prostaglandin ep3 receptor
MA39753B1 (fr) 2014-03-17 2018-10-31 Pfizer Inhibiteurs de diacylglycérol acyltransférase pour le traitement de troubles métaboliques ou analogues
MA39838B1 (fr) 2014-04-04 2019-05-31 Pfizer Composés bicycliques hétéroaryle ou aryle fusionnés et leur utilisation en tant qu'inhibiteurs irak4
MX2016013329A (es) 2014-04-10 2017-01-26 Pfizer 2-amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8h )-il-1,3-tiazol-4-ilamidas.
CN104387348A (zh) * 2014-10-27 2015-03-04 湖南华腾制药有限公司 一种苯并呋喃衍生物的制备方法
WO2016092413A1 (en) 2014-12-10 2016-06-16 Pfizer Inc. Indole and indazole compounds that activate ampk
WO2016103097A1 (en) 2014-12-22 2016-06-30 Pfizer Inc. Antagonists of prostaglandin ep3 receptor
CN107666913B (zh) 2015-03-03 2021-11-26 萨尼奥纳有限责任公司 特索芬辛，β-受体阻滞剂组合制剂
SG11201708407TA (en) 2015-05-05 2017-11-29 Pfizer 2-thiopyrimidinones
US10308615B2 (en) 2015-05-29 2019-06-04 Pfizer Inc. Heterocyclic compounds as inhibitors of Vanin-1 enzyme
KR20180004817A (ko) 2015-06-17 2018-01-12 화이자 인코포레이티드 삼환형 화합물 및 포스포다이에스터라제 억제제로서 이의 용도
WO2016203335A1 (en) 2015-06-18 2016-12-22 Pfizer Inc. Novel pyrido[2,3-b]pyrazinones as bet-family bromodomain inhibitors
BR112018002071A2 (pt) 2015-08-13 2018-09-18 Pfizer compostos heteroarílicos ou arílicos fundidos bicíclicos
AU2016311376B2 (en) 2015-08-27 2018-10-04 Pfizer Inc. Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
WO2017037567A1 (en) 2015-09-03 2017-03-09 Pfizer Inc. Regulators of frataxin
WO2017051294A1 (en) 2015-09-24 2017-03-30 Pfizer Inc. N-[2-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2h-1,2,4-thiadiazin-5-yl)-1,3-thiazol-4-yl] amides useful as bace inhibitors
AU2016325665A1 (en) 2015-09-24 2018-03-08 Pfizer Inc. N-[2-(2-amino-6,6-disubstituted-4, 4a, 5, 6-tetrahydropyrano [3,4-d][1,3] thiazin-8a (8h)-yl) -1, 3-thiazol-4-yl] amides
WO2017051303A1 (en) 2015-09-24 2017-03-30 Pfizer Inc. Tetrahydropyrano[3,4-d][1,3]oxazin derivatives and their use as bace inhibitors
GEP20207147B (en) 2015-12-29 2020-09-10 Pfizer Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors
SG11201811161YA (en) 2016-07-14 2019-01-30 Pfizer Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
AR109179A1 (es) 2016-08-19 2018-11-07 Pfizer Inhibidores de diacilglicerol aciltransferasa 2
GB201714777D0 (en) 2017-09-14 2017-11-01 Univ London Queen Mary Agent
WO2019133445A1 (en) 2017-12-28 2019-07-04 Inception Ibd, Inc. Aminothiazoles as inhibitors of vanin-1
JP7565589B2 (ja) * 2018-05-31 2024-10-11 華領医薬技術（上海）有限公司 グルコキナーゼ活性化剤およびｄｐｐ－ｉｖ阻害薬を含む医薬品の組合せ、組成物、配合剤、ならびにその調製方法および使用
CA3110601C (en) 2018-08-31 2023-09-05 Pfizer Inc. Combinations for treatment of nash/nafld and related diseases
US20210338776A1 (en) * 2018-09-06 2021-11-04 Yale University Treatments against mosquito-borne viruses based on mosquito salivary gland proteins
WO2020102575A1 (en) 2018-11-16 2020-05-22 Inception Ibd, Inc. Heterocyclic aminothiazoles and uses thereof
CA3140972C (en) 2019-05-20 2024-06-18 Pfizer Inc. Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and related diseases
TW202115086A (zh) 2019-06-28 2021-04-16 美商輝瑞大藥廠 Bckdk抑制劑
JP7498199B2 (ja) 2019-06-28 2024-06-11 ファイザー・インク 種々の疾患を処置するために有用なｂｃｋｄｋ阻害剤としての５－（チオフェン－２－イル）－１ｈ－テトラゾール誘導体
TWI771766B (zh) 2019-10-04 2022-07-21 美商輝瑞股份有限公司 二醯基甘油醯基轉移酶２ 抑制劑
TW202142538A (zh) 2020-02-07 2021-11-16 美商迦舒布魯姆生物有限公司 雜環ｇｌｐ－１促效劑
JP2022058085A (ja) 2020-02-24 2022-04-11 ファイザー・インク ジアシルグリセロールアシルトランスフェラーゼ２阻害剤とアセチル－ＣｏＡカルボキシラーゼ阻害剤との組合せ
EP4161927B9 (en) 2020-06-09 2024-11-06 Pfizer Inc. Spiro compounds as melanocortin 4 receptor antagonists and uses thereof
WO2023026180A1 (en) 2021-08-26 2023-03-02 Pfizer Inc. Amorphous form of (s)-2-(5-((3-ethoxypyridin-2-yl)oxy)pyridin-3-yl)-n-(tetrahydrofuran-3- yl)pyrimidine-5-carboxamide
TWI843301B (zh) 2021-12-01 2024-05-21 美商輝瑞股份有限公司 支鏈酮酸脫氫酶激酶（ｂｃｋｄｋ）抑制劑及／或降解劑
JP2024544021A (ja) 2021-12-06 2024-11-26 ファイザー・インク メラノコルチン４受容体アンタゴニストおよびそれらの使用
WO2023169456A1 (en) 2022-03-09 2023-09-14 Gasherbrum Bio , Inc. Heterocyclic glp-1 agonists
WO2023198140A1 (en) 2022-04-14 2023-10-19 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
WO2024075051A1 (en) 2022-10-07 2024-04-11 Pfizer Inc. Hsd17b13 inhibitors and/or degraders
AU2023364628A1 (en) 2022-10-18 2025-04-03 Pfizer Inc. Patatin-like phospholipase domain-containing protein 3 (pnpla3) modifiers
WO2024118524A1 (en) 2022-11-28 2024-06-06 Cerevel Therapeutics, Llc Azaindole compounds and their use as phosphodiesterase inhibitors
WO2024125602A1 (en) 2022-12-15 2024-06-20 Gasherbrum Bio, Inc. Salts and solid forms of a compound having glp-1 agonist activity
WO2024127297A1 (en) 2022-12-16 2024-06-20 Pfizer Inc. 3-fluoro-4-hydroxybenzmide-containing inhibitors and/or degraders and uses thereof
WO2024214038A1 (en) 2023-04-14 2024-10-17 Pfizer Inc. Glucose-dependent insulinotropic polypeptide receptor antagonists and uses thereof

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5795984A (en) * 1980-12-05 1982-06-15 Tanabe Seiyaku Co Ltd Pyridinecarboxamide derivative and its preparation
US5399564A (en) 1991-09-03 1995-03-21 Dowelanco N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides
RU2105005C1 (ru) 1992-07-03 1998-02-20 Кумиай Кемикал Индастри Ко., Лтд. Конденсированное гетероциклическое производное, способ его получения и гербицидное средство
WO1996003399A1 (de) * 1994-07-22 1996-02-08 Byk Gulden Lomberg Chemische Fabrik Gmbh Dihydrobenzofurane
DE4434637A1 (de) 1994-09-28 1996-04-04 Hoechst Schering Agrevo Gmbh Substituierte Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
WO1996011925A1 (en) * 1994-10-13 1996-04-25 Pfizer Inc. Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene b4' (ltb4) antagonists
JP2983295B2 (ja) * 1994-10-13 1999-11-29 ファイザー・インコーポレーテッド ベンゾピランおよびベンゾ縮合した化合物、それらの製造方法ならびにロイコトリエンｂ▲下４▼（ｌｔｂ▲下４▼）アンタゴニストとしてのそれらの使用
DE19603576A1 (de) 1996-02-01 1997-08-07 Bayer Ag Acylierte 4-Amino und 4-Hydrazinopyrimidine
HUP0100042A3 (en) * 1996-05-20 2003-01-28 Darwin Discovery Ltd Cambridge Benzofuran carboxamides medicaments containing the same and their therapeutic use
ES2188983T4 (es) * 1996-08-19 2004-06-01 Altana Pharma Ag Nuevas benzofuran-4-carboxamidas.
CA2317478A1 (en) * 1998-02-09 1999-08-12 Darwin Discovery Limited Benzofuran-4-carboxamides and their therapeutic use
US6492372B1 (en) * 1999-01-22 2002-12-10 Elan Pharmaceuticals, Inc. Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
SE9901573D0 (sv) 1999-05-03 1999-05-03 Astra Ab New compounds
US6777446B2 (en) 2000-09-05 2004-08-17 Tularik, Inc. FXR modulators
CA2436854A1 (en) 2000-11-20 2002-05-23 Bristol-Myers Squibb Company Pyridone derivatives as ap2 inhibitors
CN1226294C (zh) 2000-12-06 2005-11-09 霍夫曼-拉罗奇有限公司 稠合的杂芳族葡萄糖激酶活化剂
US20040180925A1 (en) 2000-12-27 2004-09-16 Kenji Matsuno Dipeptidylpeptidase-IV inhibitor
RS63203A (en) 2001-02-28 2006-12-15 Merck & Co.Inc. Acylated piperidine derivatives as melanocortin-4 receptor agonists
EP1403255A4 (en) * 2001-06-12 2005-04-06 Sumitomo Pharma RHO KINASE INHIBITORS
SE0102300D0 (sv) * 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
MXPA04003758A (es) 2001-10-22 2005-06-20 Univ New York State Res Found Inhibidores de proteina - cinasas y proteina-fosfatasas, metodos para disenarlos y metodos para usarlos.
PL218749B1 (pl) 2002-02-14 2015-01-30 Pharmacia Corp Pochodna pirydynonu oraz jej zastosowanie do wytwarzania leku
CN100357283C (zh) * 2002-04-02 2007-12-26 中国科学院上海药物研究所 一类甲硫氨酰氨肽酶抑制剂
BR0309764A (pt) 2002-05-03 2005-02-15 Warner Lambert Co Antagonistas de bombesina
EP1511733A2 (en) 2002-06-13 2005-03-09 E.I. Du Pont De Nemours And Company Pyrazole and pyrrole carboxamide insecticides
JP4302967B2 (ja) * 2002-11-18 2009-07-29 パイオニア株式会社 楽曲検索方法、楽曲検索装置及び楽曲検索プログラム
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
EP1433778A1 (en) 2002-12-23 2004-06-30 Jerini AG Use of nitriles as rotamase inhibitors
EP1594863A1 (en) 2003-02-11 2005-11-16 Prosidion Limited Tri(cyclo) substituted amide glucokinase activator compounds
TWI336329B (en) * 2003-02-13 2011-01-21 Banyu Pharma Co Ltd Novel 2-pyridinecarboxamide derivatives
CN100378094C (zh) * 2003-02-13 2008-04-02 万有制药株式会社 2-吡啶甲酰胺衍生物
CL2004000303A1 (es) 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
KR20050105488A (ko) * 2003-02-26 2005-11-04 반유 세이야꾸 가부시끼가이샤 헤테로아릴카바모일벤젠 유도체
KR20060036091A (ko) * 2003-07-15 2006-04-27 스미스클라인 비참 코포레이션 신규 화합물
ES2353306T3 (es) * 2003-08-01 2011-03-01 Chugai Seiyaku Kabushiki Kaisha Compuestos heterocíclicos útiles como inhibidores de la malonil-coa-descarboxilasa.
CL2004002050A1 (es) 2003-08-13 2005-06-03 Pharmacia Corp Sa Organizada B Compuestos derivados de piridinonas sustituidas; su uso en el tratamiento de afecciones causadas o exacerbadas por actividad p38 map kinasa y/o tnf no regulada, tales como inflamaciones, tumores, sida y otros.
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
SE0303480D0 (sv) * 2003-12-19 2003-12-19 Biovitrum Ab Benzofuranes
CA2560689C (en) 2004-04-02 2011-03-01 Novartis Ag Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
GEP20094723B (en) 2004-05-25 2009-07-10 Pfizer Prod Inc Tetraazabenzo [e] azulene derivatives and analogs thereof
CN1993347A (zh) 2004-07-29 2007-07-04 默克公司 钾通道抑制剂
WO2006028833A1 (en) 2004-09-01 2006-03-16 Rigel Pharmaceuticals, Inc. Synthesis of 2,4-pyrimidinediamine compounds
GB0420719D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
SE0403006D0 (sv) * 2004-12-09 2004-12-09 Biovitrum Ab New compounds
CA2592001A1 (en) * 2004-12-21 2006-06-29 F. Hoffmann-La Roche Ag Chroman derivatives and their use as 5-ht receptor ligands
JP4167218B2 (ja) 2004-12-22 2008-10-15 株式会社メタル建材 薄板用タッピンねじ
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
TW200700392A (en) 2005-03-16 2007-01-01 Astrazeneca Ab Novel compounds
US20090275570A1 (en) 2005-04-06 2009-11-05 Astrazeneca Ab Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
US7754717B2 (en) 2005-08-15 2010-07-13 Amgen Inc. Bis-aryl amide compounds and methods of use
KR20080040046A (ko) 2005-08-31 2008-05-07 아스텔라스세이야쿠 가부시키가이샤 티아졸 유도체
JP2009013065A (ja) * 2005-10-14 2009-01-22 Astellas Pharma Inc 縮合へテロ環化合物
WO2007058580A1 (en) 2005-11-15 2007-05-24 Astrazeneca Ab Novel 2-aminopyrimidinone derivatives and their use
EP2001875A2 (en) * 2006-03-08 2008-12-17 Takeda San Diego, Inc. Glucokinase activators
EP1999135A2 (en) 2006-03-30 2008-12-10 Takeda San Diego, Inc. Kinase inhibitors
US7842713B2 (en) * 2006-04-20 2010-11-30 Pfizer Inc Fused phenyl amido heterocyclic compounds
JP5190448B2 (ja) * 2006-04-20 2013-04-24 ファイザー・プロダクツ・インク グルコキナーゼ仲介疾患を予防および治療するための縮合フェニルアミド複素環化合物
US8163779B2 (en) 2006-12-20 2012-04-24 Takeda San Diego, Inc. Glucokinase activators
JP2010138073A (ja) 2007-03-30 2010-06-24 Taisho Pharmaceutical Co Ltd ピコリン酸アミド化合物
JP2010529109A (ja) 2007-06-08 2010-08-26 アドビナス セラピュティックス プライベート リミテッド グルコキナーゼ活性化因子としてのピロール−２−カルボキサミド誘導体、そのプロセス及び薬学的応用
WO2010084428A1 (en) * 2009-01-20 2010-07-29 Pfizer Inc. Substituted pyrazinone amides

Also Published As

Publication number Publication date
US8455496B2 (en) 2013-06-04
TW201036961A (en) 2010-10-16
CA2754681A1 (en) 2010-09-16
BRPI1013246B1 (pt) 2019-10-01
MA33119B1 (fr) 2012-03-01
UY32480A (es) 2010-10-29
US20100234285A1 (en) 2010-09-16
TWI383981B (zh) 2013-02-01
IL214942A0 (en) 2011-11-30
AU2010222589A1 (en) 2011-09-22
EA201190158A1 (ru) 2012-04-30
CO6430427A2 (es) 2012-04-30
US20130252973A1 (en) 2013-09-26
UA99882C2 (uk) 2012-10-10
EA018894B1 (ru) 2013-11-29
PT2406253E (pt) 2013-09-11
CU24036B1 (es) 2014-10-30
JP5086480B2 (ja) 2012-11-28
KR101295937B1 (ko) 2013-08-14
WO2010103437A1 (en) 2010-09-16
DK2406253T3 (da) 2013-08-12
US8735396B2 (en) 2014-05-27
NZ595024A (en) 2013-01-25
RS52903B (en) 2014-02-28
HK1164281A1 (en) 2012-09-21
AP3179A (en) 2015-03-31
AP2011005882A0 (en) 2011-10-31
CA2754681C (en) 2014-01-07
SI2406253T1 (sl) 2013-09-30
AU2010222589B2 (en) 2012-08-16
BRPI1013246A2 (pt) 2016-04-05
IL214942A (en) 2015-10-29
CN102388038B (zh) 2014-04-23
AR075729A1 (es) 2011-04-20
HRP20130661T1 (en) 2013-08-31
EP2406253B1 (en) 2013-07-03
DOP2011000279A (es) 2011-10-15
TN2011000454A1 (fr) 2013-03-27
CL2011002185A1 (es) 2012-02-03
ECSP11011306A (es) 2011-10-31
PL2406253T3 (pl) 2013-10-31
KR20110123288A (ko) 2011-11-14
GEP20156239B (en) 2015-01-26
PE20120668A1 (es) 2012-06-01
ES2427279T3 (es) 2013-10-29
CN102388038A (zh) 2012-03-21
CR20110467A (es) 2011-10-07
EP2406253A1 (en) 2012-01-18
MY151246A (en) 2014-04-30
JP2012520286A (ja) 2012-09-06
EP2604604A1 (en) 2013-06-19
ZA201106632B (en) 2012-05-30
NI201100166A (es) 2012-01-23

Similar Documents

Publication Publication Date Title
CU20110168A7 (es) Derivados de benzofuranilo
CR20110103A (es) Heteroarilos sustituidos
NI201900070A (es) Compuestos heterocíclicos como inmunomoduladores
CR20200312A (es) Nuevas piridopirimidinonas sustituidas con bencilamino y derivados como inhibidores de sos1
CO2018007528A2 (es) Compuestos heterocíclicos como inmunomoduladores
CO6551721A2 (es) Moduladores de cinasa novedosos
MX2013012896A (es) Compuestos novedosos como moduladores de proteina cinasas.
BR112014000792A2 (pt) compostos de piperidinila para uso como inibidores da tanquirase
NI201600144A (es) Derivados de quinoxalina utiles como moduladores del fgfr cinasa
CR20140397A (es) Compuestos de oxazolidin-2-ona y usos de los mismos como inhibidores de la pi3ks
DOP2012000257A (es) Derivados del acido 1-amino-2-ciclopropiletilboronico
CR20110028A (es) Derivados de pirimidina como inhibidores de cinasa
CU24187B1 (es) Derivados sustituidos de imidazopiridazinas útiles para el tratamiento o profilaxis de trastornos hiperproliferativos y la angiogénesis
ECSP12011720A (es) Compuestos heterocíclicos y usos de los mismos
MX2019003738A (es) Compuestos antivirales.
BR112015020350A2 (pt) derivados de 6-(5-hidroxi-1h-pirazol-1-il)nicotinamida e seu uso como inibidores de phd
UY32848A (es) Compuestos heterocíclicos de oxima
BR112016014020A8 (pt) moduladores de tetra-hidropiridopirazinas de gpr6.
UY34955A (es) 4-metil-2,3,5,9,9b-pentaaza-ciclopenta[a]naftalenos
CR20150248A (es) Derivados de oxazolidin-2-ona-pirimidina
ECSP13012893A (es) Ureas asimétricas y usos médicos de las mismas
ECSP11010807A (es) Sales de los compuestos del inhibidor de vih
CO6341625A2 (es) Derivados de indol como agentes anticáncer
UY32385A (es) Amidas de pirazinona sustituida
BR112015017678A2 (pt) novos derivados de pirimidina como inibidores de fosfodiesterase 10 (pde-10)

Legal Events

Date Code Title Description
FG Grant of patent